Pharmacy (Basel, Switzerland)
July 21, 2025
Paula S C C Castro, Kae Leopoldo, Maria Olivia Pozzolo Pedro et al.
2 citations
Objective: To systematically review the scientific literature on lysergic acid amide (LSA), focusing on its physical, neurobiological, and social effects, as well as its potential risks and therapeutic uses. Methods: A systematic review was conducted across PubMed, Google Scholar, and Web of Science up to December 2023, using keywords such as "ergine," "lysergic acid amide," and "legal high."...
Psychiatry Research
July 5, 2025
Maria Helha Fernandes-Nascimento, Priscila Weber, André Brooking Negrão
4 citations
LSD (lysergic Acid Diethylamide), a psychedelic compound, has been investigated in recent studies for the treatment of mental disorders. We analyzed the efficacy and safety of LSD in the treatment of mental disorders and substance use disorders in adult patients. We searched Embase, PubMed, Scopus, PsycINFO, the Cochrane Library, CENTRAL, BVS, EBSCO, Epistemonikos, and the grey literature for...
Psychedelic Medicine
January 21, 2025
Maria Helha Fernandes-Nascimento, Karine Viana-Ferreira, André Brooking Negrão
2 citations
Background: Psilocybin is a natural alkaloid with therapeutic potential in the treatment of different mental disorders. Bibliometric information on its use is still scattered in the literature. Objective: To investigate the temporal and bibliometric patterns of publications and the specificity of psilocybin in the treatment of mental disorders. Method: Performed a bibliometric analysis using...
Psicologia e Saúde em Debate
October 18, 2024
Maria Helha Fernandes-Nascimento, Karine Viana-Ferreira, Eline Nicole Assad et al.
Classic psychedelics are being globally investigated for their therapeutic potential in mental disorders, however, the literature offers little information about the progress of these studies. The aim of this study is to provide perspectives and directions on the use of classic psychedelics in the treatment of mental disorders. We conducted a bibliometric analysis of publications in the Scopus...
Journal of Psychoactive Drugs
2024
Maria Helha Fernandes-Nascimento, André Brooking Negrão, Karine Viana-Ferreira et al.
7 citations
Ibogaine is a natural psychoactive drug that has been investigated for its potential role in the treatment of substance use disorders since the mid-1960s. To evaluate the interest in ibogaine's use as a therapeutic agent, we performed a scientometric analysis covering the last three decades (1993-2002, 2003-2012, and 2013-2022). A complementary analysis was performed to select and describe...
Brain Sciences
June 24, 2023
Mariana Campello De Oliveira, Mariana Capelo Vides, Dângela Layne Silva Lassi et al.
(1) Background: Synthetic cannabinoids (SCs) are emerging drugs of abuse sold as 'K2', 'K9' or 'Spice'. Evidence shows that using SCs products leads to greater health risks than cannabis. They have been associated with greater toxicity and higher addiction potential unrelated to the primary psychoactive component of marijuana, Δ9-tetrahydrocannabinol (Δ9-THC). Moreover, early cases of...
Research Square
September 8, 2022
Maria Helha Fernandes-Nascimento, André Brooking Negrão, Karine Viana-Ferreira et al.
Abstract Objective To evaluate the publications on ibogaine use for substance-related disorders treatment over the last three decades. Method Bibliometric analysis of publications on ibogaine for the treatment of substance-related disorders from 1991 to 2020 using VOSviewer software. We performed a Scopus database search using the terms: ibogaine, 12-methoxybogamine, endabuse, tabernanthe...